Tuttle Capital Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACU
AIMCA
RCM
MI
YCM
FTUS
Tuttle Capital Management's TDACU Position: Q2 2025 in Review
Tuttle Capital Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 25,000 shares — an estimated $254K sold.
Tuttle Capital Management first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $254K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.
- Tuttle Capital Management reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
- Tuttle Capital Management sold 25,000 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $254K.
- Tuttle Capital Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
- Tuttle Capital Management's Translational Development Acquisition Corp Units position peaked at $254K in Q1 2025.
- 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.
Based on Tuttle Capital Management's 13F filing for Q2 2025, filed 28 Jul 2025.